Search

Teva Pharmaceutical Industries Ltd.

Geschlossen

BrancheGesundheitswesen

36.51 0.14

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

35.93

Max

36.77

Schlüsselkennzahlen

By Trading Economics

Einkommen

-944M

-575M

Verkäufe

161M

4.1B

KGV

Branchendurchschnitt

59.246

57.002

EPS

0.64

Gewinnspanne

-13.882

Angestellte

31,173

EBITDA

-478M

399M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+13.82% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

5.9B

42B

Vorheriger Eröffnungskurs

36.37

Vorheriger Schlusskurs

36.51

Nachrichtenstimmung

By Acuity

8%

92%

9 / 340 Ranking in Healthcare

Teva Pharmaceutical Industries Ltd. Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. Aug. 2026, 23:56 UTC

News
Social Media

Axon Enterprise shares are lower in after-market hours, following a report highlighting high valuations and recent military contracts from Bulgaria.

17. Aug. 2026, 23:56 UTC

News

Warner Bros Discovery shares are lower in after-market trading amid ongoing litigation over its merger with Paramount, which faces a $1.9 billion bond request.

17. Aug. 2026, 23:56 UTC

News

Allstate Corp shares are lower in after-market hours amid broader market weakness. Geopolitical concerns are affecting trading sentiment despite recent positive earnings highlights.

17. Aug. 2026, 23:56 UTC

News

Replimune Group Inc shares are lower in after-market hours amid negative sentiment from multiple class action lawsuits alleging securities fraud and misleading statements.

17. Aug. 2026, 23:46 UTC

Correlated Moves
News

ManpowerGroup Inc shares are lower in after-market hours amid concerns over declining sales and profitability, with operating margins reported at just 1.5%.

17. Aug. 2026, 23:46 UTC

News

Wix.com Ltd faces a securities class action lawsuit over alleged false statements about its AI offerings, contributing to shares trading roughly flat in after-hours activity.

17. Aug. 2026, 23:41 UTC

News

Coherus BioSciences announced a special dividend of contingent value rights, boosting shares in after-market trading following the company's strategic asset sale initiative.

17. Aug. 2026, 23:41 UTC

News
Social Media

XP Inc shares are lower in after-market hours after announcing a share cancellation and reporting mixed Q2 results, including adjusted net profit above estimates.

17. Aug. 2026, 23:36 UTC

News

Whirlpool Corp is identified as a sell by Yahoo Finance amid concerns over declining sales and profitability. Shares are trading lower in after-market hours.

17. Aug. 2026, 23:36 UTC

News

Enovix Corp shares are rising in after-market trading, rebounding from recent lows amid leadership changes and broader market declines for the Dow and S&P 500.

17. Aug. 2026, 23:31 UTC

News

Fred Stephan named President and CEO effective November 1, 2026.

17. Aug. 2026, 23:31 UTC

News

Zeta Global shares are lower in after-market hours, despite positive coverage highlighting strong performance and anticipated revenue growth of 25.1%.

17. Aug. 2026, 23:21 UTC

News

AT&T Inc. shares are higher in after-market trading following a successful €1.2 billion and $1.1 billion notes issuance to enhance liquidity and capital structure.

17. Aug. 2026, 23:16 UTC

News

Patterson-UTI Energy highlighted in Yahoo Finance cautionary analysis

17. Aug. 2026, 23:16 UTC

Social Media
News

Wendy's Co. shares are lower in after-market hours following the announcement of President Pete Suerken's resignation and a restructuring plan.

17. Aug. 2026, 23:16 UTC

News

Valero Energy shares are higher in after-market hours following analyst upgrades and price target increases amid rising crude oil prices linked to Middle East tensions.

17. Aug. 2026, 23:11 UTC

News

Nasdaq Inc plans to extend U.S. trading hours to nearly 23 hours daily starting December 6, 2026, pending regulatory approval. Shares are higher in after-market trading.

17. Aug. 2026, 23:06 UTC

News

DigitalOcean Holdings Inc. launched Managed AI Agents via Cloudways, contributing to shares trading higher after the market closed.

17. Aug. 2026, 23:01 UTC

News

Mitek Systems appoints Aaron Seyler as Chief Revenue Officer, effective August 17, 2026. Shares are trading higher in after-market hours.

17. Aug. 2026, 23:01 UTC

News

CACI awarded a contract worth up to $981 million with the U.S. Space Force, yet shares are trading lower in after-market hours.

17. Aug. 2026, 23:01 UTC

News

Targa Resources has secured long-term midstream agreements with ExxonMobil and plans to invest $5 billion in new projects, driving shares higher in after-market trading.

17. Aug. 2026, 23:01 UTC

News

Becton Dickinson appoints Gary Sorsher as executive vice president and chief quality officer, effective September 8. Shares are higher in after-market trading.

17. Aug. 2026, 23:01 UTC

News

Science Applications International Corp is under scrutiny after being flagged by Yahoo Finance. Shares are lower in after-hours trading following concerns over revenue projections.

17. Aug. 2026, 23:01 UTC

Correlated Moves
News
Social Media

iShares 20+ Year Treasury Bond ETF gains in after-market trading, reflecting market sentiment influenced by rising crude oil prices amid geopolitical tensions.

17. Aug. 2026, 23:01 UTC

News
Correlated Moves

BlackRock Inc shares declined in after-market trading, continuing a trend of lower daily closes amid geopolitical tensions and rising crude oil prices.

17. Aug. 2026, 22:56 UTC

Correlated Moves
News

Kulicke and Soffa Industries shares are lower in after-market trading following the announcement of Dr. Raj Talluri as the new CEO, effective September 2026.

17. Aug. 2026, 22:56 UTC

News

ComEd allocates over $170,000 to enhance public safety in 24 Illinois communities through its Powering Safe Communities Program. Exelon shares are higher in after-market trading.

17. Aug. 2026, 22:51 UTC

Social Media
News

Kura Oncology shares rose in after-market trading after CEO Troy Wilson's $1.11 million stock purchase and positive earnings report highlighting $9.1 million in revenue.

17. Aug. 2026, 20:07 UTC

News

Levi Strauss faces analyst skepticism over revenue performance and cash flow margins. The consensus price target is $28.27, implying a potential return of 26.2%.

17. Aug. 2026, 20:07 UTC

News
Correlated Moves

The iShares 7-10 Year Treasury Bond ETF is trading lower amid rising 10-year Treasury yields and geopolitical tensions affecting economic growth and inflation expectations.

Peer-Vergleich

Kursveränderung

Teva Pharmaceutical Industries Ltd. Prognose

Kursziel

By TipRanks

13.82% Vorteil

12-Monats-Prognose

Durchschnitt 41.5 USD  13.82%

Hoch 44 USD

Tief 40 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Teva Pharmaceutical Industries Ltd. – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

7 ratings

7

Buy

0

Halten

0

Sell

Stimmung

By Acuity

9 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.
help-icon Live chat